Fujisawa was established as a wholesaler of traditional Japanese and Chinese herbal medicines. The company markets ethical drugs, consumer products, medical equipment, supplies and chemicals, and home healthcare products. Fujisawa, a research-driven pharmaceutical company invests profoundly in research and development that focuses on immunology and inflammation, cardiovascular and neurological disorders, infectious and metabolic diseases and urinary disorders. The company’s principal products are Micafungin, Tacrolimus, TK-820, Atrisone™, MBI-226 and RSD-1235.